Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Medical Properties Trust's average EBITDA Per Share Growth Rate was -40.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -15.70% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -11.70% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -2.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Medical Properties Trust was 56.40% per year. The lowest was -24.10% per year. And the median was 6.60% per year.
Medical Properties Trust (MEX:MPW) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Medical Properties Trust 3-Year EBITDA Growth Rate Related Terms
MEX:MPW vs DHC, LTC, NHI: 3-Year EBITDA Growth Rate Comparison
For the REIT - Healthcare Facilities subindustry, Medical Properties Trust's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Properties Trust 3-Year EBITDA Growth Rate vs REITs Industry
For the REITs industry and Real Estate sector, Medical Properties Trust's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Medical Properties Trust's 3-Year EBITDA Growth Rate falls into.
Medical Properties Trust 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -15.70% mean?
Medical Properties Trust (MEX:MPW) has a 3-Year EBITDA Growth Rate of -15.70% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Medical Properties Trust and its competitors. According to the industry distribution chart, Medical Properties Trust ranks #501 out of 612 companies in the REITs industry, placing it in the top 81.9%.
Is Medical Properties Trust's 3-Year EBITDA Growth Rate too high?
Medical Properties Trust's current 3-Year EBITDA Growth Rate is -15.70%. Based on the distribution chart, Medical Properties Trust ranks #501 out of 612 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Medical Properties Trust has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Properties Trust's 3-Year EBITDA Growth Rate compare to DHC and LTC?
According to the REITs industry distribution chart, Medical Properties Trust ranks #501 out of 612 companies for 3-Year EBITDA Growth Rate. This places Medical Properties Trust in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 2.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a REITs company?
The median 3-Year EBITDA Growth Rate among REITs companies is 2.70, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Medical Properties Trust and its competitors. For the REITs industry, the median 3-Year EBITDA Growth Rate is 2.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Properties Trust's current 3-Year EBITDA Growth Rate is -15.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Properties Trust stock overvalued right now?
Based on GuruFocus' analysis, Medical Properties Trust (MEX:MPW) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN94.23, compared to a current price of MXN80.20 — trading 14.9% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -15.70%. Medical Properties Trust's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Medical Properties Trust (MEX:MPW), the current 3-Year EBITDA Growth Rate is -15.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Properties Trust (MEX:MPW) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Properties Trust stock appears to be undervalued.
The current stock price of MXN80.20 is trading 14.9% below its estimated GF Value™ of MXN94.23.
GuruFocus considers Medical Properties Trust to be Modestly Undervalued.
Key valuation signals for MEX:MPW:
3-Year EBITDA Growth Rate: -15.70%
GF Value™: MXN94.23 vs. price of MXN80.20 (14.9% below fair value)
No single metric tells the full story. See the MEX:MPW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. Its business strategy is to acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear of the costs associated with the property. The group's geographic areas are the United States, the United Kingdom, and All other countries.
53GF Score
Get the complete analysis for MEX:MPW
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MPW has been successfully added to your 
